Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Calgary

$27,000.00

Tumour Educated Immune Cells Contribute to Breast Cancer Progression and May Have Novel Diagnostic and Therapeutic Applications

EF 2025-26

Résumé
Breast cancer is responsible for a significant number of new cases and cancer-related deaths among women. While current diagnostic technologies like mammography and magnetic resonance imaging [MRI] have helped reduce this burden, limitations still exist such as high cost, low adherence, and poor accuracy when detecting early stage tumours. These challenges are especially prominent for underserved populations which include young women who don’t meet screening criteria, racial and ethnic minorities, and those from low socioeconomic backgrounds or rural areas. This highlights a gap in the current diagnostic process and emphasizes the need for better screening technology. Recently, there has been increasing interest in the use of blood tests to diagnose different types of cancer including breast cancer. These tests work by either directly identifying cancer in the blood stream, or by detecting the changes that occur in the rest of the body in response to cancer signals. This indirect effect that cancer has is called tumour education, and it is especially prevalent in immune cells, causing them to alter their normal behaviour and promote cancer growth. This research aims to understand how this process occurs in order to design a blood test that can recognize these changes and therefore accurately detect breast cancer, even at early stages. Additionally, these blood tests have the benefit of being minimally invasive, cost-effective, and routinely accessible which addresses many of the screening challenges that currently exist. Ultimately, this research is important for enhancing early stage detection of breast cancer which could improve healthcare inequities, improve health outcomes, and reduce breast cancer associated mortality for women.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
572701
Name
Jensen Kylie N
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Tumour Educated Immune Cells Contribute to Breast Cancer Progression and May Have Novel Diagnostic and Therapeutic Applications
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Blood-Based Detection; Breast Cancer; Early Stage Diagnosis; Immuno-Oncology; Therapeutics; Tumour Education
Abstract
Breast cancer is responsible for a significant number of new cases and cancer-related deaths among women. While current diagnostic technologies like mammography and magnetic resonance imaging [MRI] have helped reduce this burden, limitations still exist such as high cost, low adherence, and poor accuracy when detecting early stage tumours. These challenges are especially prominent for underserved populations which include young women who don’t meet screening criteria, racial and ethnic minorities, and those from low socioeconomic backgrounds or rural areas. This highlights a gap in the current diagnostic process and emphasizes the need for better screening technology. Recently, there has been increasing interest in the use of blood tests to diagnose different types of cancer including breast cancer. These tests work by either directly identifying cancer in the blood stream, or by detecting the changes that occur in the rest of the body in response to cancer signals. This indirect effect that cancer has is called tumour education, and it is especially prevalent in immune cells, causing them to alter their normal behaviour and promote cancer growth. This research aims to understand how this process occurs in order to design a blood test that can recognize these changes and therefore accurately detect breast cancer, even at early stages. Additionally, these blood tests have the benefit of being minimally invasive, cost-effective, and routinely accessible which addresses many of the screening challenges that currently exist. Ultimately, this research is important for enhancing early stage detection of breast cancer which could improve healthcare inequities, improve health outcomes, and reduce breast cancer associated mortality for women.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jensen, Kylie N
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~